URGN
UroGen Pharma Ltd.
$16.82
+$0.14(+0.81%)
51
Overall
40
Value
63
Tech
50
Quality
Market Cap
$779.09M
Volume
1.15M
52W Range
$3.42 - $21.71
Target Price
$33.75
Key Metrics Overview
| Market Cap | $779.09M | P/E Ratio | N/A |
| 52W High | $21.71 | 52W Low | $3.42 |
| Div Yield | N/A | Payout Ratio | N/A |
| EPS Growth 3Y | 15.8% | 52W Position | 73.2% |
| Overall Score | 51 | Value Score | 40 |
| Quality Score | 50 | Technical Score | 63 |
Growth Analysis
| EPS Current Est | $-3.14 | EPS Next Est | $-1.08 |
| EPS Growth Est | N/A | DPS Growth 3Y | N/A |
Revenue (5Y)
EBITDA (5Y)
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | URGN | $16.82 | +0.8% | 1.15M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |